Profile data is unavailable for this security.
About the company
Daiichi Sankyo Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceuticals. The Company is involved in the research, development, manufacture and sale of pharmaceuticals, as well as the provision of intermediates and basic materials for pharmaceutical producing in Japan, the United States, Europe and other markets. The Company is also engaged in the research, development, manufacture and sale of over-the-counter drugs and vaccines, the provision of administrative services such as human resources and accounting services, real estate leasing and insurance agency business.
- Revenue in USD (TTM)13.37bn
- Net income in USD1.98bn
- Incorporated2005
- Employees19.77k
- LocationDaiichi Sankyo Co LtdDaiichi Sankyo Bldg. A/B Kan3-5-1, Nihombashi Hon-choCHUO-KU 103-8426JapanJPN
- Phone+81 362251111
- Websitehttps://www.daiichisankyo.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Roivant Sciences Ltd | 13.31m | -809.24m | 18.93bn | 750.00 | -- | 4.40 | -- | 1,422.26 | -1.17 | -1.17 | 0.0193 | 6.02 | 0.0024 | -- | -- | 17,746.67 | -18.26 | 5.89 | -20.80 | 6.98 | 91.21 | 90.39 | -7,558.42 | 639.97 | -- | -- | 0.00 | 0.00 | -11.19 | -15.56 | -111.69 | -- | -1.32 | -- |
| Incyte Corp | 5.14bn | 1.29bn | 20.12bn | 2.84k | 15.79 | 3.88 | 14.58 | 3.91 | 6.40 | 6.40 | 25.61 | 26.04 | 0.8291 | 4.33 | 5.48 | 1,807,750.00 | 20.75 | 11.34 | 27.83 | 14.38 | 93.26 | 93.92 | 25.03 | 16.48 | 3.25 | -- | 0.0067 | 0.00 | 21.22 | 14.03 | 3,844.96 | -- | -20.67 | -- |
| United Therapeutics Corp | 3.13bn | 1.27bn | 20.39bn | 1.31k | 17.93 | 3.08 | 15.06 | 6.52 | 26.41 | 26.41 | 64.94 | 153.61 | 0.4323 | 2.21 | 9.78 | 2,397,242.00 | 17.57 | 13.61 | 19.48 | 14.84 | 88.59 | 90.79 | 40.65 | 37.81 | 6.07 | -- | 0.00 | 0.00 | 23.63 | 14.71 | 21.35 | -- | 24.11 | -- |
| Royalty Pharma plc | 2.38bn | 770.95m | 26.07bn | 100.00 | 25.38 | 4.03 | 29.14 | 10.96 | 1.78 | 1.78 | 4.21 | 11.22 | 0.1257 | -- | 84.52 | 23,781,930.00 | 7.00 | 6.72 | 9.03 | 9.10 | -- | -- | 55.68 | 50.56 | -- | 7.06 | 0.4795 | 50.52 | 5.06 | 2.30 | -10.25 | 9.26 | -4.90 | 24.01 |
| Biogen Inc | 9.89bn | 1.29bn | 28.84bn | 7.50k | 22.32 | 1.58 | 13.91 | 2.92 | 8.81 | 8.81 | 67.37 | 124.45 | 0.3441 | 1.04 | 5.30 | 1,318,747.00 | 4.50 | 6.70 | 5.32 | 7.93 | 75.69 | 78.49 | 13.07 | 17.28 | 2.03 | 5.74 | 0.2562 | 0.00 | 2.22 | -5.96 | -20.79 | -20.22 | -19.60 | -- |
| Daiichi Sankyo Co Ltd - ADR | 13.37bn | 1.98bn | 36.47bn | 19.77k | 18.00 | 3.19 | 14.78 | 2.73 | 1.07 | 1.07 | 7.19 | 6.02 | 0.5649 | 0.8183 | 3.11 | 676,355.80 | 8.38 | -- | 10.55 | -- | 77.54 | 72.15 | 14.84 | 11.03 | 1.85 | -- | 0.1495 | -- | 17.77 | 13.95 | 44.47 | 17.77 | -- | -- |
| Alnylam Pharmaceuticals, Inc. | 3.71bn | 313.75m | 41.70bn | 2.50k | 140.03 | 52.74 | 112.88 | 11.23 | 2.25 | 2.25 | 27.82 | 5.96 | 0.8068 | 8.46 | 7.20 | 1,485,575.00 | 6.82 | -12.28 | 9.57 | -16.14 | 81.64 | 83.20 | 8.45 | -24.70 | 2.71 | 3.50 | 0.7737 | -- | 65.19 | 49.77 | 212.79 | -- | -3.56 | -- |
| Zoetis Inc | 9.47bn | 2.67bn | 53.46bn | 14.50k | 21.03 | 16.16 | 16.90 | 5.65 | 6.02 | 6.02 | 21.33 | 7.84 | 0.6374 | 1.12 | 6.52 | 652,896.60 | 18.00 | 16.21 | 22.22 | 19.61 | 71.89 | 70.69 | 28.23 | 27.03 | 1.94 | 20.97 | 0.7308 | 29.07 | 2.28 | 7.24 | 7.52 | 10.29 | 6.51 | 20.11 |
Data as of Feb 13 2026. Currency figures normalised to Daiichi Sankyo Co Ltd's reporting currency: US Dollar USD
0.30%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Capital Research & Management Co. (Global Investors)as of 15 Oct 2025 | 5.19m | 0.27% |
| Azimuth Capital Investment Management LLCas of 31 Dec 2025 | 186.59k | 0.01% |
| Ramirez Asset Management, Inc.as of 31 Dec 2025 | 112.04k | 0.01% |
| Madison Asset Management LLCas of 31 Dec 2025 | 105.07k | 0.01% |
| RhumbLine Advisers LPas of 31 Dec 2025 | 44.41k | 0.00% |
| Nia Impact Advisors LLCas of 30 Nov 2025 | 33.84k | 0.00% |
| Causeway Capital Management LLCas of 05 Feb 2026 | 27.37k | 0.00% |
| BlackRock Advisors LLCas of 05 Feb 2026 | 20.16k | 0.00% |
| Yousif Capital Management LLCas of 31 Dec 2025 | 17.07k | 0.00% |
| Arctic Asset Management AS (Sweden)as of 01 Jan 2026 | 15.36k | 0.00% |
More ▼
Data from 31 Dec 2025 - 01 Jan 2026Source: FactSet Research Systems Inc.
